20-38130278-C-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004613.4(TGM2):c.2005G>A(p.Glu669Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000242 in 1,613,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004613.4 missense
Scores
Clinical Significance
Conservation
Publications
- type 2 diabetes mellitusInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000355 AC: 54AN: 152178Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000194 AC: 48AN: 247296 AF XY: 0.000210 show subpopulations
GnomAD4 exome AF: 0.000231 AC: 337AN: 1460748Hom.: 0 Cov.: 30 AF XY: 0.000266 AC XY: 193AN XY: 726498 show subpopulations
GnomAD4 genome AF: 0.000355 AC: 54AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.000363 AC XY: 27AN XY: 74460 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2005G>A (p.E669K) alteration is located in exon 13 (coding exon 13) of the TGM2 gene. This alteration results from a G to A substitution at nucleotide position 2005, causing the glutamic acid (E) at amino acid position 669 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at